Companies announce exclusive supply agreement for the life science market
April 22, 2015 (Baltimore, MD and Vendôme, France) Noxilizer, Inc., the company advancing a room temperature, NO2-based sterilization process for bio-pharmaceutical manufacturers, and Getinge-La Calhène, a leader in the isolation technologies segment, announced today an exclusive global supply agreement. Noxilizer will provide the NOX FLEX™ Rapid Bio-decontamination units for Getinge-La Calhène’s isolator systems.
Today, isolators are used throughout the bio-pharmaceutical industry. After an isolator is opened, it must be bio-decontaminated before it may be used again. The current bio-decontamination technology is hydrogen peroxide vapor (HPV), introduced over 20 years ago. The NOX FLEX™ uses nitrogen dioxide (NO2) and provides a bio-decontamination process that takes half the time of HPV, leading to improved efficiency and productivity of the manufacturing process. Another benefit of NO2 is that residual levels may be reduced to part-per-billion levels, a valuable feature for sensitive drug products, and a feature that is very difficult to achieve with HPV.
“Getinge-La Calhène is the leader in the isolation technology segment and we are excited to be working with them,” says Lawrence Bruder, Noxilizer CEO. “This is validation of the important benefits of nitrogen dioxide in sterilization and bio-decontamination for the pharmaceutical and biotech industry.”
“We are committed to bringing our customers market leading innovations. The NOX FLEX™ Rapid Bio-decontamination system demonstrates Getinge-La Calhène’s ability to bring new solutions that lead to improved efficiency and outcomes,” says, Thierry Girard, President of Getinge-La Calhène. “Focusing on the success of our customers leads to success for Getinge-La Calhène.”
Noxilizer and Getinge-La Calhène will be launching this effort at the ACHEMA meeting (June 15 – 19, 2015) in Frankfurt, Germany.
About Getinge-La Calhene:
Getinge-La Calhene supplies isolation technology and the DPTE® safe transfer system to the biopharma industry, laboratories and hospitals. From compact equipment to modular isolators for filling lines, Getinge-La Calhene provides GMP solutions for a variety of aseptic applications. The company supplies the DPTE® range of transfer ports and Beta accessories for ultra-clean transfer. Getinge-La Calhene is part of the Getinge Group, a global leading medical technology company. See more at www.getinge.com.
About Noxilizer, Inc.:
Noxilizer, Inc. provides room-temperature nitrogen dioxide sterilization technology that offers many benefits over traditional sterilization methods. Noxilizer sells sterilization and biodecontamination equipment to pharmaceutical, biotech and medical device manufacturers and also offers contract sterilization services at its Baltimore, MD facilities. Noxilizer’s expert microbiology and material compatibility team is ready to partner to solve sterilization challenges through every phase of the process. Noxilizer, Inc. is privately held with offices in the US, United Kingdom and Japan. For more information, please visit: www.noxilizer.com.
Maura O. Kahn
Vice President, Business Development & Marketing
O (443) 842-4403
C (202) 744-6337